Industry Issued Public Communication Information on YF-VAX®, Yellow Fever Vaccine Diluent and Latex

Dear Consumer:

Subject: Changes in latex content in the stopper of the diluent for reconstitution of YF-VAX® (Yellow Fever Vaccine) supplied to the Canadian market

This letter is to inform you that Sanofi Pasteur Limited is removing latex from the stopper of the 0.6 mL vial of diluent distributed in Canada for reconstitution of the YF-VAX® vaccine.

The stopper of the following diluent lots still contain latex, and will be available on the market until their expiry date presented below.

Click on the pdf for more information.